ID TRANSFAC | Gene symbol | Yes–no ratio | P | Involvement in cancer types other than HCC | Involvement in HCC |
---|---|---|---|---|---|
V$NKX61_01 | NKX6-1 | 6.17 | 5.13E−02 | Diagnostic marker [36] | Tumour promoting [37] |
V$OCT_C | POU2F1 | 6.17 | 4.20 E−05 | Tumour promoting [38] | Tumour promoting [39] |
POU2F2 | Tumour promoting [40] | Unknown | |||
V$OCT1_Q6 | POU2F1 | 4.28 | 6.61 E−05 | Tumour promoting [38] | Tumour promoting [39] |
V$VJUN_01 | JUN | 5.29 | 1.88 E−03 | Tumour promoting [41] | Predictive biomarker [42] |
V$LHX3A_01 | LHX3 | 4.85 | 1.97 E−02 | Tumour promoting [43] | Unknown |
V$IRF_Q6 | IRF1 through IRF8 | 4.7 | 4.96 E−03 | Tumour suppressing [44] | Tumour suppressing [45] |
V$E2F_03 | E2F1 | 3.29 | 6.29 E−06 | Tumour promoting [46] | Tumour promoting [47] |
V$HSF2_01 | HSF2 | 3.23 | 5.03 E−03 | Suggested tumour inhibiting [48] | Unknown |
V$SRF_Q4 | SRF | 2.94 | 7.27 E−02 | Predictive marker [49] | Tumour promoting [50] |
V$GABP_B | GABPA/ GABPB1 | 2.86 | 4.36 E−02 | Negative prognostic marker [53] | |
V$TFIIA_Q6 | GTf2A1/ GTf2A2 | 2.82 | 2.67 E−02 | General enhancement of transcription [25] | – |
V$AFP1_Q6 | ZFHX3 | 2.64 | 6.02 E−03 | Tumour suppressing [54] | Unknown |
V$PR_01 | PGR | 2.64 | 6.45 E−02 | Tumour promoting [26] | Unclear [27] |
V$CAAT_01 | cellular and viral CCAAT-box | 2.13 | 6.61 E−11 | – | – |
V$CP2_02 | TFCP2 | 2.1 | 6.98 E−04 | Tumour promoting [55] | |
V$NFY_01 | NFYA, NFYB, NFYC | 1.65 | 3.06 E−09 | Unknown | |
V$CHX10_01 | VSX2 | 1.61 | 4.73E−04 | Diagnostic marker, suggested tumour inhibiting [59] | Unknown |